Makaleler
147
Tümü (147)
SCI-E, SSCI, AHCI (122)
SCI-E, SSCI, AHCI, ESCI (134)
ESCI (12)
Scopus (131)
TRDizin (15)
Diğer Yayınlar (5)
15. Prognostic value of chemotherapy response score in advanced ovarian cancer: a single-center retrospective analysis
Sao Paulo medical journal = Revista paulista de medicina
, cilt.143, sa.6, 2025 (SCI-Expanded, Scopus)
22. The effect of parity, breastfeeding history, and duration on clinical and pathological characteristics of breast cancer patients
Turkish Journal of Medical Sciences
, cilt.54, sa.1, ss.229-238, 2024 (SCI-Expanded, Scopus, TRDizin)
26. Long-term outcomes and predictors of recurrence in node-negative early stage breast cancer patients
Journal of Cancer Research and Clinical Oncology
, cilt.149, sa.16, ss.14833-14841, 2023 (SCI-Expanded, Scopus)
28. High Level of MIR-142-3p Expressıon in Patıents with Ovarian Carcinoma
Journal of Gynecology Research
, cilt.7, sa.1, ss.1-17, 2023 (Hakemli Dergi)
36. Predictors of response in EGFR-mutant metastatic non-small cell lung cancer patients treated with tyrosine kinase inhibitors
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS
, cilt.19, sa.7, ss.1945-1949, 2023 (SCI-Expanded, Scopus)
39. Clinicopathologic characteristics and prognostic factors in patients with male breast cancer: A single tertiary center experience
JOURNAL OF CANCER RESEARCH AND THERAPEUTICS
, cilt.19, sa.7, ss.1887-1892, 2023 (SCI-Expanded, Scopus)
40. Evaluation of BRCA1/2 gene mutations in patients with high-risk breast and/or ovarian cancer in Turkey
Akdeniz Odemis D., Celik B., Kilic Erciyas S., Sukruoglu Erdogan O., Tuncer S. B., Kurt Gultaslar B., et al.
TURKISH JOURNAL OF BIOCHEMISTRY-TURK BIYOKIMYA DERGISI
, cilt.47, sa.5, ss.588-594, 2022 (SCI-Expanded, Scopus, TRDizin)
47. Are false-negative rates of sentinel lymph node biopsy after neoadjuvant chemotherapy really associated with poor prognosis in clinically node-positive disease at diagnosis?
ANNALS OF SURGICAL ONCOLOGY
, cilt.29, sa.SUPPL 1, ss.310-311, 2022 (SCI-Expanded, Scopus)
49. Skeletal system as a rare metastatic site in patients with ovarian carcinoma
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
, cilt.31, sa.8, ss.1125-1131, 2021 (SCI-Expanded, Scopus)
59. Does visceral adiposity have an effect on the survival outcomes of the patients with endometrial cancer?
JOURNAL OF OBSTETRICS AND GYNAECOLOGY RESEARCH
, cilt.47, sa.2, ss.560-569, 2021 (SCI-Expanded, Scopus)
66. Analysis of circulating microRNAs during adjuvant chemotherapy in patients with luminal A breast cancer.
Mol Clin Oncol.
, cilt.3, sa.4, ss.954-958, 2015 (Hakemli Dergi)
68. Endometrium Kanserinde Kemoterapi
Türkiye Klinikleri Jinekoloji Obstetrik
, cilt.7, sa.3, ss.100-106, 2014 (Hakemli Dergi)
71. Predictive Role of Midtreatment Changes in Survivin, GSTP1, and Topoisomerase 2 alpha Expressions for Pathologic Complete Response to Neoadjuvant Chemotherapy in Patients With Locally Advanced Breast Cancer
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
, cilt.36, sa.3, ss.215-223, 2013 (SCI-Expanded, Scopus)
73. The Frequencies of Breast Cancer BC in Extreme Ages Changing Over Time
Mediterranean Oncology Journal
, cilt.1, ss.46-19, 2012 (Hakemli Dergi)
87. Anti-Yo-associated cerebellar syndrome presenting with a brain mass
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY
, sa.2, ss.183-184, 2009 (SCI-Expanded, Scopus)
88. Malignant Ovarian Germ Cell Tumors A Single-Institution Experience
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
, cilt.32, sa.2, ss.191-196, 2009 (SCI-Expanded, Scopus)
90. International Trends and Challenges in Breast Cancer as Perceived by Leaders in Medicine, Public Policy, and Advocacy
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
, cilt.31, sa.5, ss.510, 2008 (SCI-Expanded, Scopus)
101. CYP1A1, GSTM1 and NQO1 gene polymorphisms: Genetic risk factors for small cell lung cancer
TURKISH JOURNAL OF CANCER
, cilt.35, ss.171-176, 2005 (Hakemli Dergi)
105. ANTIEMETIC EFFICACY OF DIAZEPAM IN THE PROPHYLAXIS OF ACUTE AND DELAYED EMESIS INDUCED BY CISPLATIN BASED CHEMOTHERAPY TREATED WITH STANDARD ANTI EMETICS
TURK ONKOLOJI DERGISI-TURKISH JOURNAL OF ONCOLOGY
, cilt.20, sa.2, ss.67-72, 2005 (ESCI, Scopus, TRDizin)
108. Prognostic factors in localized soft-tissue sarcomas
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
, cilt.26, sa.4, ss.411-415, 2003 (SCI-Expanded, Scopus)
109. Oral etoposide (VP16) in platinum-resistant epithelial ovarian cancer (EOC)
AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
, cilt.26, sa.4, ss.358-362, 2003 (SCI-Expanded, Scopus)
110. Prognostic factors and survival in patients with metastatic or recurrent carcinoma of the uterine cervix
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
, cilt.13, sa.4, ss.497-504, 2003 (SCI-Expanded, Scopus)
123. Utility of the serum tumor markers: CYFRA 21.1, carcinoembryonic antigen (CEA), and squamous cell carcinoma antigen (SCC) in squamous cell lung cancer.
Journal of experimental & clinical cancer research : CR
, cilt.19, sa.4, ss.477-81, 2000 (SCI-Expanded, Scopus)
127. Correlations of serum CA125 level and computerized tomography (CT) imaging with laparotomic findings following intraperitoneal chemotherapy in patients with ovarian cancer.
European journal of gynaecological oncology
, cilt.21, sa.6, ss.599-602, 2000 (SCI-Expanded, Scopus)
128. Chemotherapy in advanced breast carcinoma: Efficacy of primary and secondary or tertiary docetaxel use.
ANNALS OF ONCOLOGY
, cilt.11, ss.37, 2000 (SCI-Expanded, Scopus)
129. Long term results and prognostic factors of granulosa cell tumors of the ovary.
ANNALS OF ONCOLOGY
, cilt.11, ss.87, 2000 (SCI-Expanded, Scopus)
130. The role of chemotherapy in malignant mixed mullerian tumors of the female genital tract.
ANNALS OF ONCOLOGY
, cilt.11, ss.87-88, 2000 (SCI-Expanded, Scopus)
136. Investigation of the molecular changes during chemotherapy in non-Hodgkin's lymphoma
RESEARCH COMMUNICATIONS IN MOLECULAR PATHOLOGY AND PHARMACOLOGY
, cilt.100, sa.3, ss.301-311, 1998 (SCI-Expanded, Scopus)
137. Clinical efficacy of diazepam in prophylaxis of acute and delayed emesis induced by cisplatin based chemotherapy. A prospective randomised trial
ANNALS OF ONCOLOGY
, cilt.9, ss.146, 1998 (SCI-Expanded, Scopus)
140. Intraperitoneal cisplatin-mitoxantrone and intravenous ifosfamide combination as first-line treatment of ovarian cancer
EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY
, cilt.19, sa.3, ss.265-270, 1998 (SCI-Expanded, Scopus)
141. Catheter complications associated with intraperitoneal chemotherapy
EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY
, cilt.19, sa.3, ss.275-279, 1998 (SCI-Expanded, Scopus)
142. High-dose ifosphamide in refractory, recurrent and metastatic sarcoma
ANNALS OF ONCOLOGY
, cilt.9, ss.118, 1998 (SCI-Expanded, Scopus)
145. ECG and blood pressure changes during the 6-hours paclitaxel infusion
EUROPEAN JOURNAL OF CANCER
, cilt.33, ss.247, 1997 (SCI-Expanded, Scopus)
146. Oral etoposide in patients (pts) with Kaposi's sarcoma (KS)
EUROPEAN JOURNAL OF CANCER
, cilt.33, ss.1178, 1997 (SCI-Expanded, Scopus)
Hakemli Bilimsel Toplantılarda Yayımlanmış Bildiriler
76
2. Postmastektomi radyoterapi (PMRT)’de bolus kullanımının cilt dozuna etkisinin dozimetrik incelemesi ve PMRT uygulanan hastalarda lokal nüks değerlendirilmesi.
Tülü Çağaldoğan K., KÖKSAL AKBAŞ C., UÇAR ALVEROĞLU G., ÖZKURT S., KÜÇÜCÜK N. S., CABIOĞLU N., et al.
17. Ulusal Meme Hastalıkları Kongresi, Türkiye, 30 Kasım 2023, (Özet Bildiri)
9. EXPRESSION LEVELS OF MIR-423-5P AND MIR-664B-5P IN PATIENTSWITH FAMILIAL AND SPORADIC OVARIAN CARCINOMA
2. Uluslararası Kanser ve İyon Kanalları Kongresi, 22 - 24 Nisan 2019, (Özet Bildiri)
10. HIGH EXPRESSION LEVEL OF MIR-1260 FAMILY IN THEPERIPHERAL BLOOD OF PATIENTS WITH OVARIAN CANCER
2. Uluslararası Kanser ve İyon Kanalları Kongresi, 22 - 24 Eylül 2019, (Özet Bildiri)
14. THE INVESTIGATION OF EXPRESSION LEVELS OF MIR-16-5P, MIR-17-5P, MIR-638 IN PATIENTS WITH OVARIAN CANCER. (Özet Bildiri/Poster)(Yayın No:5876497)
2. Uluslararası Kanser ve İyon Kanalları Kongresi, 22 Eylül 2019, (Özet Bildiri)
15. The Investigation of Expression Levels of miR 16-5p, miR-17-5p, miR-638 in Patients With Ovarian Cancer
2. International cancer and ion channel congress, İzmir, Türkiye, 22 - 24 Eylül 2019, ss.43, (Özet Bildiri)
16. Rapid drug desensitization for platinum-based chemotherapy drugs significantly increases peripheral blood IL-10 levels
European Academy of Allergy and Clinical Immunology (EAACI) 2019, 1 - 05 Haziran 2019, ss.150, (Özet Bildiri)
18. Platin ile hızlı desensitizasyonun sitokin düzeylerine etkisi P -29
XXV. Ulusal Alerji ve Klinik İmmünoloji Kongresi, Antalya, Türkiye, 17 - 21 Kasım 2018, ss.111, (Tam Metin Bildiri)
19. Meme kanseri tanılı hastalarda AJCC 8 anatomik ve patolojik prognostik evreleme değişimlerinin incelenmesi
13. Ulusal Radyasyon Onkolojisi Kongresi, Türkiye, 27 Nisan - 01 Mayıs 2018, (Özet Bildiri)
23. Neoadjuvan kemoterapi uygulanan meme kanserli hastaların klinik anatomik ve klinik prognostik evre karşılaştırması
13. Ulusal Radyasyon Onkolojisi Kongresl, Türkiye, 27 Nisan - 01 Mayıs 2018, (Özet Bildiri)
27. FREQUENCY OF BRCA1 AND BRCA2 MUTATIONS IN PATIENTS WITH UNSELECTED TRIPLE-NEGATIVE BREAST CANCER
VI. International Congress of Molecular Medicine, İstanbul, Türkiye, 22 Mayıs - 25 Eylül 2017, ss.282, (Tam Metin Bildiri)
28. Serviks kanserinde nadir rastlanan metastaz bölgesi: İskiyorektal fossa
22. Ulusal Kanser Kongresi, Türkiye, 19 - 23 Nisan 2017, (Özet Bildiri)
29. 3 Boyutlu brakiterapi ile tedavi edilen serviks kanserli hastalarda akut ve geç yan etki değerlendirmesi
22. Ulusal Kanser Kongresi, Türkiye, 19 - 23 Nisan 2017, (Özet Bildiri)
30. Over Kanserinde HMGB1 ve IRE1'in Önemi
22. Ulusal Kanser Kongresi, Antalya, Türkiye, 19 - 23 Nisan 2017, ss.159, (Tam Metin Bildiri)
32. Frequency of ER,PR,HER2 and Triple Negative Hormone Receptors in BRCA1/BRCA2 Gene Mutation Positive Breast Cancer Cases
International Breastanbul Conference, İstanbul, Türkiye, 10 - 12 Kasım 2016, ss.60, (Tam Metin Bildiri)
33. Regional Distribution And Frequency Of Brca1 And Brca2 Gene Mutations In Turkish Population Including Balkan Turks
International Breastanbul Conference, İstanbul, Türkiye, 10 - 12 Kasım 2016, ss.51, (Tam Metin Bildiri)
34. Frequency of Large Deletions and Duplications in the BRCA1/2 Genes in Turkish High Risk Breast and Ovarian Cancer Cases
International Breastanbul Conference, İstanbul, Türkiye, 10 - 12 Kasım 2016, ss.7, (Tam Metin Bildiri)
35. REGIONAL DISTRIBUTIONS of BRCA1 AND BRCA2 GENE MUTATIONS IN TURKISH HEREDITARY OVARIAN CANCER PATIENTS INCLUDING BALKAN TURKS
ESGO 2016: Prevention in gynaecological malignancies, Antalya, Türkiye, 8 - 10 Eylül 2016, ss.1, (Tam Metin Bildiri)
36. BRCA1 AND BRCA2 GENE MUTATION FREQUENCY OF HIGH RISK OVARIAN CANCER CASES IN TURKISH POPULATION INCLUDING BALKAN TURKS
ESGO 2016: Prevention in gynaecological malignancies, Antalya, Türkiye, 8 - 10 Eylül 2016, ss.2, (Tam Metin Bildiri)
40. Yüksek riskli ve/veya lokal ileri evre endometriyum kanserinde eşzamanlı kemobrakiterapi
12. Ulusal Radyasyon Onkolojisi Kongresi, Türkiye, 20 - 24 Nisan 2016, (Özet Bildiri)
41. YÜKSEK RİSKLİ TÜRK MEME KANSERLİ HASTALARDA BRCA1 VE BRCA2 GENLERİNDE GÖRÜLEN SNP/VUS’LARIN DAĞILIMI
6.Türk Tıbbi Onkoloji Kongresi, Antalya, Türkiye, 23 - 27 Mart 2016, sa.246, ss.509, (Tam Metin Bildiri)
42. KAPOSİ SARKOMUNDA GENOM DÜZEYİNDE MİRNA EKSPRESYONLARININ ARAŞTIRILMASI
6.Türk Tıbbi Onkoloji Kongresi, Antalya, Türkiye, 23 - 27 Mart 2016, sa.241, ss.505, (Tam Metin Bildiri)
43. ERKEN YAŞ MEME KANSER HASTALARINDA ÇOKLU GEN ANALİZİ
6.Türk Tıbbi Onkoloji Kongresi, Antalya, Türkiye, 23 - 27 Mart 2016, sa.31, ss.238, (Tam Metin Bildiri)
44. KSHV POZİTİF VE KSHV NEGATİF KAPOSİ SARKOMLU HASTALARIN ETİYOLOJİSİNDE YENİ MİRNA’LARIN SAPTANMASI
6.Türk Tıbbi Onkoloji Kongresi, Antalya, Türkiye, 23 - 27 Mart 2016, sa.245, ss.508, (Tam Metin Bildiri)
45. Neoadjuvan kemoterapi uygulanan meme kanserli hastalarda PET BT ile tedavi yanıtının değerlendirilmesi
27. Ulusal Nükleer Tıp Kongresi, Türkiye, 1 - 05 Nisan 2015, cilt.1, ss.7
48. Kalıtsal meme kanser hastalarında saptanan BRCA1 2 gen mutasyonlarının bölgesel ve etnik dağılımı ile klinik özellikleri
5. Türk Tıbbi Onkoloji Kongresi, Antalya, Türkiye, 19 - 23 Mart 2014
49. KALITSAL MEME KANSER HASTALARINDA SAPTANAN BRCA1/2 GEN MUTASYONLARININ BÖLGESEL VE ETNİK DAĞILIMI İLE KLİNİK ÖZELLİKLERİ
5. türk tıbbi onkoloji kongresi, Antalya, Türkiye, 19 - 23 Mart 2014, (Tam Metin Bildiri)
50. Epitelyal Over Kanserli Hastalarda Yüksek Serum Epidermal Büyüme Faktör Reseptörü (EGFR) Düzeyleri Kötü Progresyonsuz Sağkalımla İlişkilidir
5. Türk Tıbbi Onkoloji Kongresi, Antalya, Türkiye, 19 - 23 Mart 2014, ss.428, (Tam Metin Bildiri)
51. Serum Transforme Edici Büyüme Faktörü-Beta1 (TGF-B1) Seviyelerinin Epitelyal Over Kanserli Hastalarda Klinik Önemi
5. Türk Tıbbi Onkoloji Kongresi, Antalya, Türkiye, 19 - 23 Mart 2014, ss.421, (Tam Metin Bildiri)
52. Serum Hücresel Adhezyon Molekülleri (VCAM-1, EPCAM) Seviyelerinin Meme Kanserli Hastalarda Tanısal, Prediktif ve Prognostik Rolü
5. Türk Tıbbi Onkoloji Kongresi, Antalya, Türkiye, 19 - 23 Mart 2014, ss.493, (Tam Metin Bildiri)
53. Epitelyal Over Kanserinin Belirlenmesi Üzerinde Protease Activated Receptor-1(PAR-1) Düzeylerinin Herhangi Bir Tanısal Değeri Var Mıdır?
5. Türk Tıbbi Onkoloji Kongresi, Antalya, Türkiye, 19 - 23 Mart 2014, ss.421, (Tam Metin Bildiri)
54. Serum Makrofaj Migrasyon İnhibitör Faktörü (MIF) Düzeylerinin Epitelyal Over Kanserli Hastalarda Tanısal, Prediktif ve Prognostik Rolü
5. Türk Tıbbi Onkoloji Kongresi, Antalya, Türkiye, 19 - 23 Mart 2014, ss.420, (Tam Metin Bildiri)
55. 2008-2012 Yılları Arasında Kanser Genetiği Polikliniğine Başvuran Yüksek Riskli Meme/Over Kanser Sendromlu Vakalarının Dağılımı
20. ULUSAL KANSER KONGRESİ, Antalya, Türkiye, 19 - 23 Nisan 2013, (Tam Metin Bildiri)
57. MKC yapılmış T1 2 N1 M0 hastalarda tedavi sonuçları ve prognostik faktörlerin değerlendirilmesi
10. Ulusal Radyasyon Onkolojisi Kongresi, Türkiye, 19 - 23 Nisan 2012
58. The predictive role of midtreatment changes in survivin, GSTP1 and Topoisomerase 2 alpha expressions for pathologic complete response to neoadjuvant chemotherapy in patients with locally advanced breast cancer
2011 ASCO Annual Meeting, Amerika Birleşik Devletleri, 1 - 04 Haziran 2011, ss.10539, (Tam Metin Bildiri)
59. Nine versus52 weeks of adjuvant trastuzumab in early breast cancer:An observational study of the Turkısh Oncology Group
JOURNAL OF CLINICAL ONCOLOGY, Alexandrıa, Amerika Birleşik Devletleri, 20 Mayıs 2011, cilt.29, sa.15, ss.629, (Özet Bildiri)
60. The ımpact of 21 gene recurrence score (RS)scores on treatment decisions:Retrospective evaluation in Turkish early-stage breast cancer(BC)patients
JOURNAL OF CLINICAL ONCOLOGY, Alexandrıa, Amerika Birleşik Devletleri, 20 Mayıs 2011, cilt.29, sa.5, (Özet Bildiri)
61. The changing pattern of risk factors and disease characteristics of breast cancer in Turkey:Across-sectional study of a Turkısh oncology group(BREASTTURK)
JOURNAL OF CLINICAL ONCOLOGY, Alexandrıa, Amerika Birleşik Devletleri, 20 Mayıs 2011, cilt.29, sa.15, (Özet Bildiri)
62. Phase II study of lapatinib in combination with vinorelbine in patients with ErbB2-amplified recurrent or metastatic breast cancer
JOURNAL OF CLINICAL ONCOLOGY, Alexandrıa, Amerika Birleşik Devletleri, 20 Mayıs 2011, cilt.29, sa.15, (Özet Bildiri)
63. Association between glutathione s-transferase P1 polymorphisms and time to tumor progression in small cell lung cancer patients
JOURNAL OF CLINICAL ONCOLOGY, Alexandrıa, Amerika Birleşik Devletleri, 20 Mayıs 2010, cilt.28, sa.15, (Özet Bildiri)
64. Phase II study of loading-dose ibandronate treatment in patients in breast cancer and bone metastases suffering from moderate to severe pain
JOURNAL OF CLINICAL ONCOLOGY, Alexandrıa, Amerika Birleşik Devletleri, 20 Mayıs 2010, cilt.28, sa.15, (Özet Bildiri)
65. The future of breast cancer research and practice in Asia, Latin America, and the Middle East/North Africa: a qualitative horizon scanning analysis.
31st Annual San Antonio Breast Cancer Symposium, Phıladelphıa, Amerika Birleşik Devletleri, 15 Ocak 2009, cilt.69, sa.2, ss.328-329, (Özet Bildiri)
66. Size Distrubution Circulating Cell-Free DNA In Sera of Breast Cancer Patients In Course of Adjuvant Therapy
Symposium on Circulating Nucleic Acids in Plasma/Serum -V, Rusya, 1 - 04 Ağustos 2007, ss.9, (Tam Metin Bildiri)
67. Size distribution o circulating cell-free DNA in sera of breast cancer aptients in course of adjuvant therapy
Symposium on Circulating Nucleic Acids in Plasma Serum-V, Rusya, 1 - 04 Ağustos 2007, ss.9, (Tam Metin Bildiri)
74. Oral etoposide in patients with small cell lung cancer
EUROPEAN JOURNAL OF CANCER, Oxford, Birleşik Krallık, 01 Eylül 1997, cilt.33, sa.8, ss.1072, (Özet Bildiri)
75. Oral etoposide in patients (pts) with Kaposi's sarcoma (KS)
EUROPEAN JOURNAL OF CANCER, Oxford, Birleşik Krallık, 01 Eylül 1997, cilt.33, sa.8, ss.1178, (Özet Bildiri)
76. Küçük hücreli dışı, akciğer kanserlerinde palyatif tedavide radyoterapi sonrası kemoterapinin yeri
I. Ulusal Radyasyon Onkolojisi Kongresi, İzmir, Türkiye, 16 - 18 Mayıs 1994, ss.1563, (Tam Metin Bildiri)
Kitaplar
2
2. Uykusuzluk
Onkoloji Hemşireliğinde Kanıttan Uygulamaya, Can Gülbeyaz, Editör, Nobel Tıp Kitabevi, İstanbul, ss.39-50, 2014